Liu J, Li P, Zhang Y, Zheng L
Sci Rep. 2025; 15(1):8209.
PMID: 40065044
PMC: 11893791.
DOI: 10.1038/s41598-025-91299-z.
Wen X, Hu A, Presnell S, Ford E, Koelle D, Kwok W
Nat Commun. 2025; 16(1):2332.
PMID: 40057520
PMC: 11890790.
DOI: 10.1038/s41467-025-57562-7.
Parween F, Singh S, Kathuria N, Zhang H, Ashida S, Otaizo-Carrasquero F
Nat Commun. 2025; 16(1):1978.
PMID: 40000641
PMC: 11861662.
DOI: 10.1038/s41467-025-57002-6.
Cao L, Peng H, Chen Y, Xia B, Zeng T, Guo J
J Immunother Cancer. 2024; 12(11).
PMID: 39532433
PMC: 11555110.
DOI: 10.1136/jitc-2024-010028.
King H, Lewin S
Immunol Rev. 2024; 328(1):350-371.
PMID: 39248154
PMC: 11659942.
DOI: 10.1111/imr.13388.
Immune regulation and therapeutic application of T regulatory cells in liver diseases.
Ajith A, Merimi M, Kazem Arki M, Hossein-Khannazer N, Najar M, Vosough M
Front Immunol. 2024; 15:1371089.
PMID: 38571964
PMC: 10987744.
DOI: 10.3389/fimmu.2024.1371089.
The wild mouse bone marrow has a unique myeloid and lymphoid composition and phenotype.
Muir A, Bennett A, Smith H, Logunova L, Wolfenden A, Fenn J
Discov Immunol. 2024; 2(1):kyad005.
PMID: 38567065
PMC: 10917185.
DOI: 10.1093/discim/kyad005.
Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
Raineri D, Abreu H, Vilardo B, Kustrimovic N, Venegoni C, Cappellano G
Int J Mol Sci. 2024; 25(5).
PMID: 38473756
PMC: 10932052.
DOI: 10.3390/ijms25052509.
Sex-specific differences in ICOS T helper cell differentiation in systemic lupus erythematosus patients with low disease activity.
Wu L, Kalble F, Lorenz H, Zeier M, Schaier M, Steinborn A
Clin Exp Med. 2024; 24(1):47.
PMID: 38427068
PMC: 10907489.
DOI: 10.1007/s10238-024-01307-1.
Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy.
Ebrahimi N, Abdulwahid A, Mansouri A, Karimi N, Bostani R, Beiranvand S
Cell Mol Life Sci. 2024; 81(1):106.
PMID: 38418707
PMC: 10902086.
DOI: 10.1007/s00018-023-05098-8.
The Role of the CD28 Family Receptors in T-Cell Immunomodulation.
Ciesielska-Figlon K, Lisowska K
Int J Mol Sci. 2024; 25(2).
PMID: 38279272
PMC: 10816057.
DOI: 10.3390/ijms25021274.
Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils.
Zhou A, Shi C, Fan Y, Zheng Y, Wang J, Liu Z
Front Immunol. 2023; 14:1171308.
PMID: 37325657
PMC: 10267736.
DOI: 10.3389/fimmu.2023.1171308.
Granulocyte-Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade.
Li X, Li J, Zheng Y, Lee S, Zhou J, Giobbie-Hurder A
Cancer Immunol Res. 2023; 11(8):1100-1113.
PMID: 37262321
PMC: 10398357.
DOI: 10.1158/2326-6066.CIR-22-0702.
Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy.
Yin L, Li X, Zhu L, Chen G, Xiang Z, Wang Q
Front Immunol. 2022; 13:965120.
PMID: 36131929
PMC: 9483102.
DOI: 10.3389/fimmu.2022.965120.
Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotype.
Elizondo C, Bright J, Bright R
Hum Vaccin Immunother. 2022; 18(6):2108656.
PMID: 36069634
PMC: 9746449.
DOI: 10.1080/21645515.2022.2108656.
The proportion and phenotypic changes of CD4CD25Foxp3 T cells in patients with untreated rheumatoid arthritis.
Ju B, Zhu L, Wang J, Zheng J, Hao Z, Luo J
BMC Immunol. 2022; 23(1):41.
PMID: 36064312
PMC: 9446710.
DOI: 10.1186/s12865-022-00517-0.
ICOS is upregulated on T cells following radiation and agonism combined with radiation results in enhanced tumor control.
Blair T, Baird J, Bambina S, Kramer G, Gostissa M, Harvey C
Sci Rep. 2022; 12(1):14954.
PMID: 36056093
PMC: 9440216.
DOI: 10.1038/s41598-022-19256-8.
Inducible Costimulator-C-X-C Motif Chemokine Receptor 3 Signaling is Involved in Chronic Obstructive Pulmonary Disease Pathogenesis.
Li D, Chen L, Miao S, Zhou M, Wu J, Sun S
Int J Chron Obstruct Pulmon Dis. 2022; 17:1847-1861.
PMID: 35991707
PMC: 9386059.
DOI: 10.2147/COPD.S371801.
Murine precursors to type 1 conventional dendritic cells induce tumor cytotoxicity and exhibit activated PD-1/PD-L1 pathway.
Molina M, Hoffman E, Stokes J, Kummet N, Simpson R, Katsanis E
PLoS One. 2022; 17(8):e0273075.
PMID: 35980974
PMC: 9387840.
DOI: 10.1371/journal.pone.0273075.
Circulating Exhausted PD-1CD39 Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade.
Martinez-Gomez C, Michelas M, Scarlata C, Salvioni A, Gomez-Roca C, Sarradin V
Cancers (Basel). 2022; 14(15).
PMID: 35954341
PMC: 9367599.
DOI: 10.3390/cancers14153679.